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Glycerol-3-phosphate acyltransferase (GPAT) cata-
lyzes the initial and rate-limiting step of glycerolipid
synthesis. Two distinct GPAT isoenzymes had been
identified in mammalian tissues, an N-ethylmaleimide
(NEM)-sensitive isoform in the endoplasmic reticulum
membrane (microsomal GPAT) and an NEM-resistant
form in the outer mitochondrial membrane (mtGPAT).
Although only mtGPAT has been cloned, the microsomal
and mitochondrial GPAT isoforms can be distinguished,
because they differ in acyl-CoA substrate preference,
sensitivity to inhibition by dihydroxyacetone phosphate
and polymixin B, temperature sensitivity, and ability to
be activated by acetone. The preponderance of evidence
supports a role for mtGPAT in synthesizing the precur-
sors for triacylglycerol synthesis. In mtGPAT/ mice,
PCR genotyping and Northern analysis showed success-
ful knockout of mtGPAT; however, we detected a novel
NEM-sensitive GPAT activity in mitochondrial fractions
and an anti-mtGPAT immunoreactive protein in liver
mitochondria, but not in microsomes. Rigorous analysis
using two-dimensional gel electrophoresis revealed that
the anti-mtGPAT immunoreactive proteins in wild type
and mtGPAT/ liver mitochondria have different iso-
electric points. These results suggested the presence of a
second GPAT in liver mitochondria from mtGPAT/
mice. Characterization of this GPAT activity in liver
from mtGPAT null mice showed that, unlike the mtG-
PAT activity in wild type samples, activity in mtGPAT
knockout mitochondria did not prefer palmitoyl-CoA,
was sensitive to inactivation by NEM, was inhibited by
dihydroxyacetone phosphate and polymixin B, was tem-
perature-sensitive, and was not activated by acetone.
We conclude that a novel GPAT (mtGPAT2) with anti-
genic epitopes similar to those of mtGPAT is detectable
in mitochondria from the livers of mtGPAT/ mice.
The initial and rate-limiting step of glycerolipid synthesis is
the acylation of glycerol 3-phosphate with long-chain fatty acyl-
CoA to form 1-acyl-glycerol 3-phosphate (LPA).1 This reaction
is catalyzed by two glycerol-3-phosphate acyltransferase
(GPAT; EC 2.3.1.15) isoenzymes that are encoded by different
genes (1). One isoform is present in the endoplasmic reticulum
membrane (microsomal GPAT), and the other is located in the
outer mitochondrial membrane (mtGPAT). Although the micro-
somal GPAT has not been cloned or purified, its activity is
easily distinguished, because, unlike mtGPAT, the microsomal
isoform is inhibited by sulfhydryl reagents (2). In most tissues,
the microsomal GPAT activity is 10 times higher than that
found in the mitochondrial fraction, but in liver, mtGPAT con-
tributes 30–50% of the total activity (1).
Microsomal GPAT and mtGPAT also differ in their acyl-CoA
substrate preference. The microsomal isoform esterifies both
saturated and unsaturated long-chain acyl-CoAs equally well,
but mtGPAT prefers C16:0-CoA (2). In rat liver, kidney, and
heart, mtGPAT activity is 3–10-fold higher with C16:0-CoA
than with other long-chain saturated or unsaturated acyl-CoA
substrates (3–6). The activity of recombinant mouse mtGPAT
purified from an insect cell expression system is 2-fold higher
with C16:0-CoA than with C18:1-, C18:2n6-, C18:3n3-, or C20:
4n6-CoA (7). Because most naturally occurring glycerolipids
contain saturated fatty acids at the sn-1 position and unsatur-
ated fatty acids at the sn-2 position, it was proposed that
mtGPAT establishes the initial asymmetric distribution of
fatty acids (4). This hypothesis was borne out by studies with
GPAT/ mice showing that, compared with the wild-type
mice, their liver phosphatidylethanolamine and phosphatidyl-
choline have 20% less palmitate in the sn-1 position and 36–
40% more arachidonate in the sn-2 position (8). These results
confirm both the important role mtGPAT plays in the position-
ing of 16:0 at the sn-1 position of phospholipids and its indirect
role in positioning 20:4 at the sn-2 position.
Although the microsomal GPAT is present in the same sub-
cellular membrane fraction as the terminal enzymes for TAG
synthesis, physiological data suggest that TAG formation is
regulated by the mitochondrial isoform (1, 8–10). Because only
the mitochondrial GPAT isoform has been cloned (11, 12),
changes in activity of the two isoenzymes can be compared, but
not changes in mRNA abundance or protein expression. In
general, mtGPAT mRNA, protein, and activity in liver and
adipose tissue increase with carbohydrate feeding and with
insulin stimulation, whereas microsomal GPAT activity does
not change (11, 13–15). In addition, mtGPAT mRNA is up-
regulated by sterol regulatory element-binding protein-1c, a
potent activator of lipogenesis (16). The role for mtGPAT in
up-regulating TAG synthesis is also supported by studies of
overexpressed rat mtGPAT in Chinese hamster ovary cells.
Expression of recombinant rat mtGPAT in Chinese hamster
ovary cells results in a 3.8-fold increase in NEM-resistant
GPAT activity, a 4-fold increase in [14C]oleate incorporation
into TAG, and a 30% decrease in [14C]oleate incorporation into
phospholipids (10). To confirm the critical role of mtGPAT in
the regulation of TAG synthesis, mtGPAT null mice were gen-
erated (8). The knockout mice weigh less than controls and
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have reduced gonadal fat pad weights, lower hepatic TAG
content, a lower plasma TAG and very low density lipoprotein
TAG, and decreased secretion of TAG from liver (8). These data
suggest that mtGPAT is required for normal synthesis of TAG
in both fat cells and hepatocytes but show that the microsomal
GPAT also contributes.
We were surprised to find that mitochondria isolated from
liver of mtGPAT/ retained considerable GPAT activity but
that this activity, unlike that of mtGPAT, was inactivated by
NEM. Further, an anti-GPAT immunoblot analysis of
GPAT/ liver mitochondria detected an immunoreactive pro-
tein with approximately the same molecular mass as mtGPAT.
Rigorous analysis using two-dimensional gel electrophoresis
revealed that the anti-mtGPAT immunoreactive proteins in
wild type and mtGPAT/ liver mitochondria had different
isoelectric points. These results suggested the presence of a
second mtGPAT isoform. Further characterization showed
that, unlike the mtGPAT activity in wild type samples, the
NEM-sensitive GPAT activity in mitochondria from liver of
knockout animals did not prefer C16:0-CoA, was inhibited by
DHAP and polymixin B, was temperature-sensitive, and was
not activated by acetone. We conclude that liver mitochondria
from mtGPAT/ mice express a novel GPAT activity.
EXPERIMENTAL PROCEDURES
Chemicals—All chemicals were purchased from Sigma if not other-
wise indicated. [2-3H]Glycerol was from PerkinElmer Life Sciences.
Lipid standards were from Doosan Serdary Research Laboratories.
Animals—Animal protocols were approved by the University of
North Carolina at Chapel Hill Institutional Animal Care and Use
Committee. Male mtGPAT/ and wild type mice were genotyped by
PCR as described previously (8). Mice were housed on a 12-h/12-h
light/dark cycle with free access to water and Prolab RMH 3000 SP76
chow.
Preparation of Mouse Liver Mitochondrial and Microsomal Frac-
tions—Two-month-old male mtGPAT deficient mice and male wild type
mice were anesthetized with Avertin (0.01 ml/g of body weight) and
killed by cervical dislocation. Liver was removed immediately, minced,
and placed in Medium 1  DTT (250 mM sucrose, 10 mM Tris, pH 7.4,
1 mM EDTA, 1 mM DTT). Tissue was homogenized with 10 up and down
strokes in a Teflon-glass homogenizing vessel and centrifuged at 600 
g for 5 min to remove large debris and nuclei. Mitochondria were
obtained by centrifuging the supernatant at 10,300  g for 10 min. The
microsomal fraction was acquired by centrifuging the supernatant for
1 h at 100,000  g. Liver mitochondrial and microsomal fractions were
stored in aliquots at 80 °C. Protein concentrations were determined
by the bicinchoninic acid method (Pierce) using bovine serum albumin
as the standard.
Purity of the Mitochondrial and Microsomal Fractions—Purity of the
liver subcellular fractions was established by measuring the activity of
marker enzymes, NADH cytochrome c reductase (17), and cytochrome c
oxidase (cytochrome c oxidase kit; Sigma), for endoplasmic reticulum
and mitochondria, respectively.
Immunoblotting—Proteins were separated on an 8% polyacrylamide
gel containing 1% SDS, transferred to a polyvinylidene fluoride mem-
brane (Bio-Rad), and incubated with antibody against recombinant rat
mtGPAT expressed in bacteria and gel-purified from inclusion bodies.
For chemiluminescent detection, the immunoreactive bands were visu-
alized by incubating the membrane with horseradish peroxidase-conju-
gated goat anti-rabbit IgG and PicoWest reagents (Pierce). For two-
dimensional analyses, mitochondria (1 mg of protein) were added to 600
l of rehydration buffer containing 7 M urea, 2 M thiourea, 0.5% (v/v)
Biolytes 3–10 (Bio-Rad), 50 mM Tris-HCl, 1% ASB-14 (Calbiochem) and
1% Triton X-100, and 2 mM tributyl phosphine. The sample was mixed
and sonicated in a water bath sonicator for 5 min. The sample was
incubated for an additional 40 min at room temperature and centri-
fuged at 13,000  g to pellet the insoluble particulate. Immobilized pH
gradient gel strips (Bio-Rad) were rehydrated overnight (12–16 h) at 50
V with rehydration buffer containing the protein sample. Proteins were
separated on a protein isoelectric focusing cell (Bio-Rad) for 60,000 V-h.
The immobilized pH gradient gel strip was conditioned for 15 min with
250 V, and then the voltage was raised to 30,000 V over 3 h. After
isoelectric focusing, the immobilized pH gradient gel strips were incu-
bated for 10 min with shaking in equilibration buffer (6 M urea, 2% SDS,
20% glycerol, 0.15 M Tris-HCl) containing 130 mM DTT and subse-
quently in rehydration buffer containing 135 mM iodoacetamide for an
additional 10 min with shaking. The immobilized pH gradient gel strips
were placed on an 8% polyacrylamide gel containing 1% SDS to sepa-
rate proteins in the second dimension. Immunoblotting was performed
as described above.
Glycerol 3-Phosphate Synthesis and GPAT Assay—sn-[2-3H]Glycerol
3-phosphate was synthesized enzymatically from [2-3H]glycerol (1 mCi/
ml), purified, and assayed as described (18). GPAT activity was assayed
in a 200-l mixture containing 75 mM Tris-HCl, pH 7.5, 4 mM MgCl2, 1
mg/ml bovine serum (essentially fatty acid-free), 1 mM DTT, 8 mM NaF,
800 M [3H]glycerol 3-phosphate, and 80 M palmitoyl-CoA (19). The
reaction was initiated by adding 15–30 g of mitochondrial or microso-
mal protein to the assay mix. All assays were performed for 10 min at
room temperature unless indicated. Assay modifications are indicated
in the figures. All experiments were performed at least twice.
Lipid Analysis—Products from the GPAT assay were pooled, dried,
and resuspended in chloroform. The lipids were spotted on a Silica G
plate (Whatman) together with standards for LPA, phosphatidic acid,
and diacylglycerol. The chromatograms were developed in CHCl3/pyri-
dine/formic acid (88%) (50:30:7). The plates were exposed to iodine
vapor, and the bands corresponding to LPA, phosphatidic acid, and
diacylglycerol were scraped into scintillation vials containing Cyoscint
(ICN) for scintillation counting.
RESULTS
Mitochondrial GPAT/ Liver Mitochondria Contain an
NEM-sensitive GPAT Activity—Mitochondrial GPAT (mtG-
PAT) knockout mice were generated by replacing a 0.5-kb
genomic sequence encoding part of the active site with neo and
confirmed by PCR genotyping (8). To make certain that we had
truly eliminated mtGPAT in the knockout mouse, we probed
RNA from mtGPAT /, /, and / mice with two probes
for rat mtGPAT, Probe A (nt 785–1582, 0.8 kb) and Probe B (nt
1583–2194, 0.6 kb). The active site of mtGPAT is composed of
homology regions I (nt 679–717), II (nt 814–834), III (nt 934–
969), and IV (nt 1039–1062) (20). Regions II–IV are contained
within Probe A. The targeting construct deletes a 0.5-kb region
of genomic DNA that contains homology regions II and III.
Neither Probe A nor Probe B, which together encode 53% of the
open reading frame, identified an RNA band in liver from
mtGPAT/ mice (8). These previously published Northern
analyses demonstrate that mtGPAT/ mice lack expression of
the mtGPAT transcript.
Therefore, we were surprised to find that the mitochondria of
mtGPAT/ mice contained a GPAT activity that was sensitive
to NEM inhibition. Thus, we undertook a careful study of the
novel GPAT activity in highly pure mitochondrial fractions
(Table I) from livers of wild type and mtGPAT null mice.
Historically, the GPAT activity in mitochondria has been meas-
ured as NEM-resistant glycerol-3-phosphate acyltransferase
activity, because sulfhydryl reagents only inhibit the GPAT
activity present in microsomes (2). In our initial characteriza-
tion of the mtGPAT null mice, we assayed liver total membrane
fractions in the presence and absence of NEM. In these total
membrane fractions, GPAT activity in the presence of NEM
TABLE I










mol/min % mol/min %
Mitochondria
/ 0.03 3.6 14.69 94.2
/ 0.05 2.0 15.33 98.3
Microsomes
/ 0.70 96.4 0.90 5.8
/ 2.5 98.0 1.72 1.7
a Total activity in each fraction.
b Percentage of total activity in all fractions.
Mitochondrial Glycerol-3-phosphate Acyltransferase-2 13489
was only 8% of the NEM-resistant activity observed in wild
type mice (8), consistent with the amount of residual microso-
mal GPAT activity that is usually observed after NEM treat-
ment (21, 22). The NEM-sensitive GPAT activities were similar
in wild type and mtGPAT knockout mice. Highly purified mi-
tochondria from mtGPAT/ mice, however, contained sub-
stantial GPAT activity that was 60% of the activity present in
mitochondria from wild type mice (1.0 nmol/min/mg) (Fig. 1A).
When the labeled glycerolipid products formed in the assays for
GPAT activity in mitochondria were analyzed by TLC, a simi-
lar distribution of LPA, phosphatidic acid, and diacylglycerol
was observed in samples from wild type and mtGPAT null mice
(Fig. 1B). We reasoned that the GPAT activity still present in
mitochondria from the knockout must be an NEM-sensitive
enzyme. To confirm this hypothesis, liver mitochondria from
wild type and mtGPAT null mice were assayed for GPAT ac-
tivity with increasing concentrations of NEM (Fig. 2). GPAT
activity in wild type mitochondria was stable in the presence of
0.4 mM NEM as previously reported (2); however, as little as
0.05 mM NEM inhibited 75% of activity in mitochondria from
mtGPAT/ mice. These data clearly distinguish GPAT activ-
ity in wild type and knockout animals and show that the GPAT
activity in liver mitochondria from mtGPAT null mice is NEM-
sensitive, similar to the microsomal GPAT (Table II).
Mitochondria from mtGPAT/ Mice Contain a GPAT Im-
munoreactive Protein—Liver mitochondria from the mtG-
PAT/ mice contained an anti-mtGPAT immunoreactive pro-
tein with a molecular mass (90 kDa) similar to that of mtGPAT
(Fig. 3A). The mitochondria were not contaminated with endo-
plasmic reticulum (Table I), and no immunoreactive protein
was detected in the microsome fraction (Fig. 3A), consistent
with previous reports that the microsomal and mitochondrial
GPAT isoforms are distinct (1, 2, 11) and that their amino acid
sequences are very different. A two-dimensional Western blot
analysis was performed in order to distinguish the anti-GPAT
immunoreactive proteins in wild type and mtGPAT/ liver
mitochondria. The immunoreactive protein detected in mtG-
PAT knockout mouse liver had a different isoelectric point than
the protein detected in wild type mice (Fig. 3B). In the upper
panel, two major bands (labeled 1 and 2) and several minor
bands were detected in a mixed sample of liver mitochondria
from wild type and mtGPAT null mice. In samples containing
liver mitochondria from mtGPAT/ mice (lower panel), band 1
(presumably mtGPAT) is absent, whereas band 2 remains.
Since the antibody used was raised against full-length recom-
binant rat mtGPAT protein, we suspected that the novel im-
munoreactive protein was a novel GPAT isoenzyme with con-
siderable amino acid sequence similarity to mtGPAT.
Kinetic Characterization of GPAT Activity in GPAT/ Liver
Mitochondria—The NEM sensitivity of GPAT activity in
knockout liver mitochondria indicated the presence of a new
GPAT isoenzyme. To further characterize this isoenzyme, we
determined the Km for the two substrates, glycerol 3-phosphate
(G3P) and acyl-CoA. The apparent Km for G3P in wild type
mitochondria was 400 M (Fig. 4A) and in the same range (670
M) as previous studies of purified recombinant mouse mtG-
PAT (7). The apparent Km for G3P in mitochondria from the
mtGPAT null mice was similar (300 M). Microsomal GPAT
had an apparent Km for G3P of 140 M (Fig. 4B).
Palmitoyl-CoA is the preferred substrate for mtGPAT (2);
unsaturated fatty acyl-CoA species, like oleoyl-CoA, give a
maximum velocity that is 2–9-fold lower (3–6). The only com-
parative study of mouse mtGPAT showed that recombinant
enzyme purified from insect cells had a 2-fold preference for
C16:0-CoA compared with C18:1 at 25 M (7). In mtGPAT/
FIG. 2. GPAT activity in mtGPAT/ liver mitochondria is
NEM-sensitive. GPAT-specific activity was determined in liver mito-
chondria from wild type (●) and mtGPAT knockout (E) mice. Samples
were preincubated on ice at the indicated NEM concentrations for 15
min. The GPAT assay was performed at room temperature with 20 g
of protein. Each value represents the average of two determinations.
GPAT-specific activities at 0 mM NEM (100%) were 0.80 nmol/min/mg
for wild type and 0.50 nmol/min/mg for mtGPAT knockout liver mito-
chondria. Data are from a representative experiment repeated three
times.
FIG. 1. Purified mitochondria from mtGPAT/ mice retain GPAT activity. GPAT-specific activity was determined in liver mitochondria
from wild type (/) and mtGPAT knockout (/) mice as described under ‘‘Experimental Procedures.’’ A, the bars represent GPAT-specific
activity. Values are means  S.D. of eight independent mitochondria isolations and were analyzed by paired Student’s t test (*, p  0.002). B, LPA,
phosphatidic acid, and diacylglycerol were separated by TLC as described under ‘‘Experimental Procedures.’’ The bars represent the percentage
of total counts (/, 3028 cpm; /, 2210 cpm) collected from the plate and are the average of two independent experiments that varied by less
than 10%.
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liver mitochondria, no difference in apparent Vmax was ob-
served between C18:1- and C16:0-CoA substrates, but wild type
liver mitochondria showed a 30% preference for C16:0-CoA as
compared with C18:1-CoA at 75 M (Fig. 4C). In wild type and
mtGPAT/ mice, the apparent Km values for C16:0- and C18:
1-CoA could not be calculated because of inhibition at concen-
trations higher than 75 M.
The lack of a preference for C16:0-CoA for activity from
mtGPAT null mitochondria closely resembles that of the mi-
crosomal GPAT isoenzyme (2). Because the microsomal GPAT
from rat fat cells and liver also acylates DHAP, which acts as a
competitive inhibitor (19, 21), we measured the ability of
DHAP to inhibit GPAT activity. Increasing concentrations of
DHAP inhibited [3H]G3P acylation in mitochondria from mtG-
PAT/ liver but not in wild type (Fig. 5A). The Ki for DHAP
was calculated to be 545 M (Fig. 5B), similar to previous
reports for rat microsomal GPAT (19, 23). Mouse liver micro-
somal GPAT activity was not inhibited by DHAP at 1.75 mM
when 800 M [3H]G3P was present in the assay (Fig. 5A), but at
200 M [3H]G3P, both mouse and rat liver microsomal GPAT
were inhibited 30% (data not shown), similar to previous as-
says that used lower G3P concentrations (19). Thus, we con-
clude that DHAP is a competitive inhibitor of the novel GPAT
activity present in knockout liver mitochondria. The suscepti-
bility to inhibition by DHAP is similar to microsomal GPAT,
whereas in wild type mitochondria, DHAP does not inhibit
mtGPAT activity.
GPAT Activity in mtGPAT/ Liver Mitochondria Is Tem-
perature-sensitive, Inhibited by Polymixin B, and Unresponsive
to Acetone Activation—Microsomal and mtGPAT activities are
differently affected by temperature, polymixin B, acetone,
salts, and chelators (2), so we examined the effects of these on
mitochondrial GPAT activities from wild type and GPAT/
liver mitochondria (Table II). GPAT activities in microsomes,
wild type mitochondria, and knockout mitochondria were max-
imal under similar assay conditions (pH 7–7.5, 4 mM MgCl2, 1
mg/ml bovine serum albumin, 8 mM NaF, and 1 mM DTT). The
addition of monovalent salts (NaCl, KCl) and chelators (EDTA,
EGTA) did not differently affect GPAT activities. Malonyl-CoA,
a potent inhibitor of carnitine palmitoyl transferase 1, did not
inhibit or activate GPAT activity in wild type or knockout
mitochondria. LPA, the product of the GPAT reaction, inhibits
GPAT activity equally well in mitochondria from wild type and
mtGPAT/ mice, similar to previous reports (24).
Since microsomal GPAT activity is inhibited 50% after pre-
incubation for 7 min at 40.5 °C (19), we tested the temperature
FIG. 3. Liver mitochondria from mtGPAT/ mice contain a
novel anti-GPAT immunoreactive protein. Liver mitochondria and
microsomes were isolated from wild type and mtGPAT null mice. A,
protein (100 g) was analyzed by Western blot with mtGPAT anti-
serum. Lanes 1 and 2, wild type mitochondria and microsomes, respec-
tively. Lanes 3 and 4, knockout mitochondria and microsomes, respec-
tively. Molecular mass markers are indicated on the right side. B,
mitochondrial proteins (1 mg) were first subjected to isoelectric focusing
and then separated by SDS-PAGE and immunoblotted with mtGPAT
antiserum. Upper panel, 1:1 mixture of mitochondria from wild type
and mtGPAT/ mice. Lower panel, mitochondria from mtGPAT/
liver only. pI is indicated at the top, calculated molecular mass is
indicated on the right, and arrows 1 and 2 indicate the position of major
species recognized by the mtGPAT antibody.
TABLE II
Mitochondrial GPAT activity from wild type and mtGPAT/ mice responds differently to temperature, NEM, polymixin B, acetone, and salts
GPAT-specific activity was determined in liver mitochondria from wild type (/) and mtGPAT knockout (/) mice and in microsomes from
wild type (/) mice. All values represent the average of duplicates from a representative experiment repeated at least twice. Control activities
in the different preparations ranged from 2.5–7 nmol/min/mg for microsomes, 0.7–1.5 nmol/min/mg for wild type mitochondria, and 0.3–0.9
nmol/min/mg for knockout mitochondria.
Assay modifications




pH 7–7.5 100 100 100
MgCl2 4 mM
b 100 100 100
Bovine serum albumin 1 mg/mlb 100 100 100
NaF 8 mMb 100 100 100
DTT 1 mMb 100 100 100
NaCl 125 mM 100 100 NDd
KCl 125 mM 100 100 ND
Oleoyl-LPA 200 M 13 20 ND
Palmitoyl-LPA 100 M 24 23 ND
40.5 °C 4 minc 79 39 72
NEM 0.075 mM 114 14 7
Acetone 20 l 195 95 ND
CaCl2 1 mM 70 33 ND
EDTA 1 mM 90 90 171
EGTA 1 mM 90 61 151
a Mitochondrial and microsomal fractions were highly purified (Table I).
b The indicated concentrations gave the highest NEM-sensitive and NEM-resistant GPAT-specific activities.
c Preincubation time.
d ND, not determined.
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sensitivity of mtGPAT. In contrast to GPAT activity in wild
type mitochondria, GPAT activity from mtGPAT/ liver mito-
chondria was sensitive to heating, with 80% of the glycerol-3-
phosphate acyltransferase activity lost after incubation for 4
min at 40.5 °C (Fig. 6A, Table II). Polymixin B, an antibiotic
that interacts with membranes, inhibits microsomal GPAT and
activates mtGPAT (25, 26). In liver mitochondria from
GPAT/ mice, 0.1 mg/ml Polymixin B inhibited GPAT activity
80%, similar to microsomal GPAT, whereas mtGPAT from wild
type mice was only inhibited 20% (Fig. 6B, Table II). In con-
trast to previous reports, we did not observe activation of wild
type mtGPAT, because our assay contained 10-fold lower con-
centrations of polymixin B (25, 26). Because both elevated
temperature and polymixin B perturb the phospholipid envi-
ronment (27), we cannot rule out the possibility that the mem-
brane composition of wild type and knockout liver mitochon-
dria might differ enough to alter sensitivity to temperature and
polymixin B (8).
Additional differences between GPAT activity in wild type
and knockout liver mitochondria were observed with the addi-
tion of acetone or CaCl2 to the acyltransferase assay. Previous
studies have reported that 5–10% acetone in the assay mix
increases rat mtGPAT activity 200%, whereas the microsomal
activity is inhibited or unaffected (2). Acetone increased GPAT
activity 195% in wild type mitochondria, but no change was
observed in mitochondria from mtGPAT/ mice (Fig. 6C). The
addition of 1 mM CaCl2 inhibited GPAT activity in mitochon-
dria from wild type and mtGPAT null mice, 33 and 70%, re-
spectively (Fig. 6D). These data further strengthen our hypoth-
esis that a novel GPAT isoenzyme is present in liver
mitochondria from mtGPAT null mice.
DISCUSSION
GPAT is a critical enzyme in glycerolipid synthesis because it
catalyzes the initial and committed step required for the for-
mation of triacylglycerol and all of the glycerophospholipids.
Historically, two distinct GPAT isoenzymes have been identi-
fied, an NEM-sensitive isoform present in the endoplasmic
reticulum membrane and an NEM-resistant enzyme present in
the outer mitochondrial membrane. It now appears that an
additional mitochondrial GPAT isoform exists, bringing the
total to three. We propose the following nomenclature for the
GPAT isoenzymes: erGPAT for the microsomal enzyme, mtG-
PAT1 for the originally cloned mitochondrial GPAT, and mtG-
PAT2 for the new activity characterized in this paper.
Southern and Northern analyses showed absence of the tar-
FIG. 4. GPAT dependences on glycerol 3-phosphate, palmitoyl-CoA, and oleoyl-CoA in wild type and mtGPAT/ liver. GPAT-
specific activity was determined in liver mitochondria (A) and microsomes (B) from wild type (●) and mtGPAT knockout (E) mice. The glycerol
3-phosphate concentration varied as indicated. Palmitoyl-CoA was held constant at 80 M. The assay was initiated with 20 g of protein. C,
GPAT-specific activity was determined in liver mitochondria from wild type (solid symbols) and mtGPAT knockout (open symbols). Each reaction
mixture contained 20 g of protein and palmitoyl-CoA (●) or oleoyl-CoA (Œ) concentrations as indicated. Glycerol 3-phosphate was held constant
at 800 M. Data are from representative experiments repeated three times.
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geted mtGPAT in the mtGPAT/ mice, and the phenotype of
these animals included decreases in liver TAG and alterations
in the acyl composition of the glycerophospholipids (8). How-
ever, when we assayed liver mitochondria and microsomes
from mtGPAT1/ mice, we discovered that unlike mitochon-
dria from wild type liver, the knockout liver mitochondria
contained an NEM-sensitive GPAT activity (mtGPAT2) (Fig.
2). The existence of an NEM-sensitive GPAT in knockout liver
mitochondria coincides with the presence of an anti-mtGPAT
immunoreactive protein (mtGPAT2) with a similar molecular
mass (90 kDa), but a different isoelectric point than GPAT from
wild type liver mitochondria (Fig. 3). It is not surprising that
the rat mtGPAT antiserum recognized another glycerol-3-phos-
phate acyltransferase, since the antibody was raised against
full-length recombinant rat liver mtGPAT, and GPAT and
1-acyl-glycerol acyltransferase isoforms share a high degree of
amino acid similarity, although the low molecular masses of
the 1-acyl-glycerol acyltransferases (30–40 kDa) preclude misi-
dentification of these isoforms (9). In a similar fashion, anti-
body raised against full-length rat long-chain acyl-CoA synthe-
tase-1 recognizes three isoforms, acyl-CoA synthetase-1, -4,
and -5 (28). The mtGPAT antiserum did not detect any protein
in liver microsomes (Fig. 3A), suggesting that the erGPAT
differs significantly from the mitochondrial isoforms. We be-
lieve that mtGPAT2 is compensatorily up-regulated in mtG-
PAT1 null mice, because the appearance of a new anti-mtG-
PAT1 immunoreactive protein coincides with the detection of a
mitochondrial NEM-sensitive GPAT activity whose character-
istics are distinct from those of mtGPAT1.
An alternative explanation for these data would be that
mtGPAT has two splice variants, that our targeting construct
eliminated only one of the variants, and that the increased
GPAT activity in mtGPAT1/ liver mitochondria is due to a
compensatory increase in the amount of the alternate mRNA.
We do not believe this is the case, because Northern analyses
(8), performed with probes that encompassed 53% of the open
reading frame including two critical motifs that have been
proven essential for acyltransferase activity (20), failed to de-
tect any message in mtGPAT1/ mice. In addition, the enzy-
matic characteristics of GPAT in knockout liver mitochondria
differ considerably from wild type.
Although mtGPAT2 must contain one or more epitopes rec-
ognized by antibodies raised against mtGPAT1, its enzymatic
properties differ substantially from those of mtGPAT1. mtG-
PAT2 activity (measured in liver mitochondria from mtGPAT1-
deficient mice) is inhibited by NEM, clearly differentiating this
activity from the NEM-resistant mtGPAT1. In addition, these
data refute the possibility that mtGPAT2 is a reported inner
mitochondrial membrane GPAT, because this (as yet uncloned)
GPAT activity was NEM-resistant (29).
Further attributes also distinguish mtGPAT2 from mtG-
PAT1 and other acyltransferases. mtGPAT2 uses saturated
and unsaturated acyl-CoAs equally well and is competitively
inhibited by DHAP, properties exhibited by erGPAT but not
mtGPAT1. Also, unlike mtGPAT1, mtGPAT2 is temperature-
sensitive, inhibited by polymixin B, and not stimulated by
acetone. Although the properties of mtGPAT2 are reminiscent
of erGPAT, the activity cannot reflect the microsomal isoform,
because our mitochondrial fractions contained less than 4% of
the endoplasmic reticulum marker NADPH cytochrome c re-
ductase (Table I), and the immunoblot analysis showed no
anti-mtGPAT immunoreactive protein in microsomal fractions
under any conditions (Fig. 3A). In addition, mtGPAT2 activity
is not likely to be a previously described mitochondrial DHAP
acyltransferase activity, because this (uncloned) activity is
NEM-resistant (30). Taken together, the appearance of a
unique anti-mtGPAT immunoreactive protein in mtGPAT/
liver mitochondria corresponds with a distinct GPAT activity,
similar in its enzymatic properties to those of erGPAT, but not
detectable in wild type mitochondria.
Identification of a second mtGPAT isoform may shed some
light on previously reported discrepancies in GPAT protein
expression versus activity. Previous studies in rats show that,
compared with liver and adipose tissue, mtGPAT protein ex-
pression is high in heart and adrenal gland but that NEM-
resistant GPAT activity is low (20). It is likely that mtGPAT2
is expressed in these tissues and recognized by the antibody.
An NEM-sensitive mtGPAT2 activity in mitochondria would
not have been detected, because (a) activity was assayed in a
total membrane preparation, and (b) the GPAT activity was
measured in the presence of NEM (8). To determine whether
the heart and adrenal proteins are really mtGPAT2 will re-
quire measurement of NEM-sensitive and -resistant GPAT
activity in highly purified mitochondrial and microsomal frac-
tions from each tissue. Although the function of mtGPAT2 is
not known at this juncture, it is clearly distinct from mtGPAT1,
because mtGPAT1/ mice weigh less and have reduced go-
nadal fat pad weights, lower hepatic TAG content, lower
plasma TAG, low density lipoprotein TAG, and decreased he-
patic TAG secretion (8). Since the novel mtGPAT2 cannot sub-
FIG. 5. DHAP inhibits GPAT activity in mtGPAT/ liver mitochondria. A, liver microsomes (Œ) and mitochondria from wild type (●) and
mtGPAT knockout (E) mice were assayed at 800 M [3H]G3P with increasing concentrations of DHAP (0–1750 M) as indicated. GPAT-specific
activities at 0 M DHAP (100%) were 3.2 nmol/min/mg for microsomes, 1.6 nmol/min/mg for wild type mitochondria, and 1.1 nmol/min/mg for
knockout mitochondria. Data are from a representative experiment repeated three times. B, liver mitochondria from mtGPAT/ mice were
assayed with increasing concentrations of [3H]G3P and fixed concentrations of DHAP, 0 M (Œ), 1000 M (E), and 1500 M (●). Data are from a
representative experiment repeated three times.
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stitute for the ability of mtGPAT1 to synthesize TAG in fat cells
and hepatocytes, we propose that mtGPAT2 may function in
catalyzing the initial step in the synthesis of mitochondrial
phospholipids (see below). This hypothesis is consistent with
the presence of mtGPAT2 activity in wild type and mtG-
PAT1/ heart,2 a tissue rich in mitochondria.
Since none of the unique properties of mtGPAT2 (NEM sen-
sitivity, temperature sensitivity, lack of acetone stimulation,
and DHAP inhibition) were observed in wild type liver mito-
chondria, it appears that mtGPAT2 may be up-regulated in
mtGPAT1/ mouse liver, possibly to maintain a critical level
of mitochondrial glycerolipids. mtGPAT1 is highly homologous
to the sole bacterial GPAT (PlsB) (9, 20). By extension from the
immunoblot data (Fig. 1), mtGPAT2 is also likely to be similar
to PlsB, which initiates the synthesis of the phospholipids
prominent in mitochondria (phosphatidylglycerol, cardiolipin,
and phosphatidylserine). Many mitochondrial proteins have a
bacterial origin, and mtGPAT1 and -2 are both probably de-
rived from plsB. Functionally, mtGPAT1 contributes to the
synthesis of TAG, a product absent from most bacteria; there-
fore, mtGPAT2 could be important for synthesizing mitochon-
drial phospholipids, similar to PlsB. Full-length mtGPAT1 pro-
tein is 21% identical to Escherichia coli PlsB, and mtGPAT
amino acid residues 153–444, which contain the motifs re-
quired for substrate binding and catalysis (9), is 42% identical
to E. coli PlsB (14). A BLAST search of the mouse data base
using acyltransferase homology regions I–IV (20) reveals the
presence of many potential acyltransferases, one of which may
be mtGPAT2. Several glycerolipid and cholesterol ester syn-
thetic enzymes (acyl-CoA:cholesterol acyltransferases 1 and 2,
1-acyl-glycerol acyltransferases 1–6, cytidylyltransferases 
and , diacylglycerol acyltransferases 1 and 2, monoacylglyc-
erol acyltransferase 1–3, phosphatidylethanolamine methyl-
transferases 1 and 2, and phosphatidylserine synthases 1 and
2) have two or more isoforms that probably have distinct func-
tions (9, 31–45). Although characterization of mtGPAT2 func-
tion awaits the completion of molecular cloning, it is fascinat-
ing to contemplate that endoplasmic reticulum phospholipid
synthesis, mitochondrial phospholipid synthesis, and TAG syn-
thesis may be initiated by distinct GPAT isoenzymes.
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